![Brian F. Pockett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Brain F.
Pockett is Chief Operating Officer and Managing Director of Bio-Matrix Scientific Group, Inc. and a Delaware corporation (the Seller).
Previously, he was Chief Operating Officer and Managing Director of Frezer, Inc. and Founder of PD&C.
Mr. Pockett received a BA degree from Azusa Pacific University and a Theology Degree from Crestmont Seminary.
Former positions of Brian F. Pockett
Companies | Position | End |
---|---|---|
RIVULET MEDIA, INC. | Chief Operating Officer | 31/05/2009 |
Frezer, Inc.
![]() Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Chief Operating Officer | 21/02/2007 |
Tasco Holdings International, Inc. | Chief Operating Officer | 04/09/2006 |
Bio-Matrix Scientific Group, Inc. /Old/ | Chief Operating Officer | 27/08/2006 |
Training of Brian F. Pockett
Azusa Pacific University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RIVULET MEDIA, INC. | Technology Services |
Private companies | 3 |
---|---|
Bio-Matrix Scientific Group, Inc. /Old/ | Health Technology |
Tasco Holdings International, Inc. | Finance |
Frezer, Inc.
![]() Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
- Stock Market
- Insiders
- Brian F. Pockett